摘要:
VO2 and V2O5 nano- or micro-materials. The VO2 nano-materials and micro-materials have an M1 phase structure and oxygen stoichiometry that deviates 2% or less from theoretical stoichiometry. The VO2 nano-materials and micro-materials may doped with cation dopants and/or anion dopants. The VO2 and V2O5 nano- or micro-materials can be made by hydrothermal methods starting with V3O7.H2O nano- or micro-material. The VO2 and V2O5 nano- or micro-materials can be used as, for example, thermochromic window coatings.
摘要:
This disclosure relates to methods for promoting bone formation or reducing bone destruction. This disclosure also relates to methods for promoting the recruitment of mesenchymal stem cells (MSC) to a local site of injury or surgical intervention in bone to promote healing. In addition, this disclosure relates to methods for reducing or preventing mineral formation or bone growth, or reducing bone mass. The methods disclosed herein are useful for treating conditions such as osteoradionecrosis.
摘要:
This document provides methods and materials for treating diabetes and/or liver steatosis. For example, methods for using compositions containing a potato polysaccharide preparation to reduce one or more symptoms of diabetes or liver steatosis are provided. In some cases, a composition containing a potato polysaccharide preparation provided herein can be used to treat fatty liver disease.
摘要:
Cross-linked proteins and peptides, and methods of making and uses of such cross-linked proteins and peptides. The cross-linked proteins and peptides have rigid, distance-matching bismethylene aryl cross-linking moieties. Compositions comprising the cross-linked proteins and peptides can be used as pharmaceutical delivery formulations. The cross-linked proteins and peptides can have improved properties, such as cell permeability, as compared to the parent protein or peptide.